Exton, PA, United States of America

Brian D Gray

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 3.2

ph-index = 1


Location History:

  • Malvern, PA (US) (2016 - 2020)
  • Exton, PA (US) (2015 - 2021)

Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: Brian D Gray: Innovator in Phenolic Lipids and Anti-Thrombotic Agents

Introduction

Brian D Gray is a notable inventor based in Exton, Pennsylvania, with a focus on innovations in the field of biochemistry and pharmaceuticals. He holds a total of five patents, showcasing his contributions to the development of novel compounds and methods that have significant implications in medical treatments.

Latest Patents

Among his latest patents, Gray has developed compositions that include iodinated phenolic lipids and methods for their iodination. These compositions feature a phenol group conjugated to a lipid group, which may include a fluorophore and at least one lipid anchor. The lipid anchor can range from 7 to 22 carbon atoms. Additionally, he has described methods for iodinating hydrophobic compounds, such as phenolic lipids, in aqueous-based iodination protocols. Another significant patent involves anti-thrombotic agents and methods for treating platelet-related diseases, highlighting his commitment to addressing critical health issues.

Career Highlights

Throughout his career, Brian D Gray has worked with various organizations, including Molecular Targeting Technologies, Inc. and the University of Massachusetts. His work has contributed to advancements in medical research and the development of therapeutic agents.

Collaborations

Gray has collaborated with notable colleagues, including Koon Y Pak and Mary Rusckowski, further enhancing the impact of his research and innovations.

Conclusion

Brian D Gray's contributions to the fields of phenolic lipids and anti-thrombotic agents underscore his role as a significant inventor in the medical and pharmaceutical industries. His innovative work continues to pave the way for advancements in treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…